0.14 0 (0%) | 03-09 16:00 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 0.18 | 1-year : | 0.23 |
Resists | First : | 0.16 | Second : | 0.19 |
Pivot price | 0.15 | |||
Supports | First : | 0.1 | Second : | 0.08 |
MAs | MA(5) : | 0.14 | MA(20) : | 0.14 |
MA(100) : | 0.41 | MA(250) : | 0.46 | |
MACD | MACD : | -0.1 | Signal : | -0.1 |
%K %D | K(14,3) : | 27.1 | D(3) : | 33.9 |
RSI | RSI(14): 43.7 | |||
52-week | High : | 1.2 | Low : | 0.09 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ TMDI ] has closed above bottom band by 22.7%. Bollinger Bands are 80.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 46 bars. This is a sign that the market may be about to initiate a new trend.
If tomorrow: | Open lower | Open higher |
High: | 0.15 - 0.15 | 0.15 - 0.15 |
Low: | 0.12 - 0.12 | 0.12 - 0.12 |
Close: | 0.14 - 0.14 | 0.14 - 0.14 |
Titan Medical Inc., a medical technology company, focuses on the development and commercialization of robotic assisted surgical technologies for application in minimally invasive surgery. It is developing the Enos system, a robotic single access surgical system that includes a surgeon-controlled patient cart comprising a 3D high-definition vision system and multi-articulating instruments for performing surgical procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during surgical procedures. The company is headquartered in Toronto, Canada.
Sun, 03 Mar 2024
Titan Medical Inc (NASDAQ:TMDI) Rising From The Dead After Robotic Surgery Breakthrough - Insider Financial
Thu, 09 Mar 2023
Nasdaq delists Titan Medical amid mass layoffs, failed sale - Fierce Biotech
Thu, 12 Jan 2023
Titan Medical shows off Enos surgical robot's next-gen design - Medical Design & Outsourcing
Thu, 12 Jan 2023
Titan Medical meets with strategic buyers and investors as surgical robot developer considers its future - Mass Device
Thu, 10 Nov 2022
Titan Medical to seek share consolidation to keep Nasdaq listing - Mass Device
Sun, 05 Dec 2021
Titan Medical Stock: We're On Sidelines (NASDAQ:TMDI) - Seeking Alpha
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
Exchange:
NASDAQ
|
|
Sector:
Healthcare
|
|
Industry:
Medical - Devices
|
|
Shares Out | 112 (M) |
Shares Float | 112 (M) |
Held by Insiders | 0 (%) |
Held by Institutions | 4.5 (%) |
Shares Short | 52 (K) |
Shares Short P.Month | 253 (K) |
EPS | -0.16 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 0.05 |
Profit Margin | -210.5 % |
Operating Margin | -378.7 % |
Return on Assets (ttm) | -69.5 % |
Return on Equity (ttm) | -129.9 % |
Qtrly Rev. Growth | 0 % |
Gross Profit (p.s.) | 0.17 |
Sales Per Share | 0.08 |
EBITDA (p.s.) | -0.34 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | -32 (M) |
Levered Free Cash Flow | -33 (M) |
PE Ratio | -0.87 |
PEG Ratio | 0 |
Price to Book value | 2.31 |
Price to Sales | 1.55 |
Price to Cash Flow | -0.49 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | 2018-06-18 |
Ex-Dividend Date | Invalid DateTime. |